维普中文期刊产品整合服务
20篇 您的检索式:作者名="Jilaveanu"
    题名 作者 年代 出处 被引量
1帕博利珠单抗治疗伴脑转移NSCLC患者的一项非随机、开放Ⅱ期试验的长期随访结果和生物标志物分析显示文摘背景与目的我们开展了一项帕博利珠单抗用于伴未治疗脑转移的非小细胞肺癌(non-small cell lung cancer,NSCLC)或黑色素瘤患者的疗效和安全性的II期试验,旨在评估程序性死亡受体1(programmed cell death 1,PD-1)抑制剂在中枢神经系统(central nervous system,CNS)中的疗效。中期结果已发表,现报道对NSCLC队列的更新分析结果。方法这是一项开放性、单中心、II期试验。纳入标准:年龄≥18岁,诊断为晚期NSCLC并伴有≥1个5 mm-20 mm脑转移病灶,既往从未治疗或之前放疗后进展,无神经系统症状,不需要激素治疗且美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)<2分。患者每2周接受一次帕博利珠单抗(10 mg/kg)治疗。队列1为程序性死亡配体1(programmed cell death ligand 1,PD-L1)≥1%的患者,队列2为PD-L1<1%或未评估的患者。主要终点是脑转移患者缓解比例。所有经治患者均纳入疗效与安全性终点的分析。该研究已结束入组,并于Clinicaltrials.gov登记注册,注册号为NCT02085070。结果2014年3月31日-2018年5月21日,共42例患者接受治疗。中位随访时间为8.3个月(IQR:4.5个月-26.2个月)。队列1的37例患者中11例有脑转移缓解[29.7%(95%CI:15.9%-47.0%)]。队列2未观察到缓解。治疗相关的3级-4级不良事件(adverse events,AEs)包括2例肺炎、1例全身症状、1例结肠炎、1例肾上腺皮质功能不全、1例高血糖症和1例低钾血症。6例(14%)患者发生了治疗相关的严重不良事件,包括肺炎、急性肾损伤、低钾血症和肾上腺皮质功能不全。没有观察到治疗相关死亡病例。结论帕博利珠单抗治疗PD-L1≥1%的NSCLC伴脑转移患者有效,且对所有纳入的未经治疗的脑转移患者安全。需要进一步探索免疫治疗用于NSCLC合并CNS转移。Sarah B GOLDBERG Kurt A SCHALPER Scott N GETTINGER Amit MAHAJAN Roy S HERBST Anne C CHANG Rogerio LILENBAUM Frederick H WILSON Sacit Bulent OMAY James B YU Lucia JILAVEANU Thuy TRAN Kira PAVLIK Elin ROWEN Heather GERRSH Annette KOMLO Richa GUPTA Hailey WYATT Matthew RIBEIRO Yuval KLUGER Geyu ZHOU Wei WEI Veronica L CHANG Harriet M KLUGER 董晓荣(翻译/校对) 2021中国肺癌杂志2021,24,9:34
2Quantitative expres- sion of VEGF, VEGF - R1, VEGF - R2, and VEGF - R3 in mela- noma tissue microarrays显示文摘Mehnert JM Mc-Carthy MM Jilaveanu L 2010Hum Pathol2010,41,3:1
3Identification of Cucumber green mottle mosaic virus in Romanla显示文摘Pop I Jilaveanu A 1985Analele Institutulul de Cercetari - pentru Protectia Plantelor1985,18,:1
4Quanti-tative expression of VEGF, VEGFR-1, VEGFR-2 andVEGFR-3 in melanoma tissue microarrays 显示文摘Mehnert JM Mc Carthy MM Jilaveanu I 2010HumPathol2010,41,3:1
5Quantitative expres-sion of VEGF,VEGF-R1,VEGF-R2,and VEGF-R3 in melanoma tis-sue microarrays显示文摘Mehnert J M McCarthy M M Jilaveanu L 2010Hum Pathol2010,41,3:1
6Quantitative expres-sion of VEGF,VEGF-R1,VEGF-R2,and VEGF-R3 in melanoma tissue microarrays显示文摘Mehnert JM McCarthy MM Jilaveanu L 2010Hum Pathol2010,41,3:1
7Chemotherapy and biologic therapies for melanoma:do they work显示文摘Jilaveanu LB SA Aziz HM Kluger 0,,06:1
8Identification of cucumber green mottle virus in Romania显示文摘Pop I Jilaveanu A 1985Analele Institutului de Cercetari Pentru Protectia Plantelor1985,18,:1
9PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma? 显示文摘Barr ML Jilaveanu LB Camp RL 2015J Clin Pathol2015,68,:1
10Studies of NVP-BEZ235 in melanoma显示文摘Sznol JA Jilaveanu LB Kluger HM 2013Curr Cancer Drug Targets2013,13,2:1
11Quantitative expres- sion of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melano- ma tissue microarrays显示文摘MehnertJM McCarthy MM Jilaveanu L 2010Hum Pathol2010,41,3:1
12Identification of cucumber green mottle virus in Romania显示文摘POP I JILAVEANU A 1985AnaIeIe InstitutuIui de Cercetari Pentru Protectia Plantelor1985,18,:1
13CD70 expression patterns in renal cell carcinoma显示文摘JILAVEANU L B SZNOL J AZIZ S A 0,,09:1
14Identification of Cucumber green mottle virus in Romania显示文摘Pop I Jilaveanu A 1985Analele Institutului de Cercetari Pentru Protectia Plantelor1985,18,:1
15Identification of Cucumber green mottle virus in Romania显示文摘Pop I Jilaveanu A 1985Analele Institutului de Cercetari Pentru Protectia Plantelor1985,18,:1
16Advances in therapy for melanoma brain metastases显示文摘Flanigan JC Jilaveanu LB Chiang VL 2013Clin Dermatol2013,31,3:1
17Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells显示文摘Zito CR Jilaveanu LB Anagnostou V 2012PLoS One2012,7,31:1
18PD-L1 expression in clear cell renal cell carcinoma: An analysis of nephrectomy and sites of metastases显示文摘Jilaveanu LB Shuch B Zito CR 2014J Cancer2014,5,3:1
19Identification of Cucumber green mottle virus in Romania显示文摘Pop I Jilaveanu A 1985Analele Institutului de Cercetari Pentru Protectia Plantelor1985,18,:1
20Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue mieroarrays 显示文摘Mehnert JM McCarthy MM Jilaveanu L 2010Hum Patho12010,41,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费